CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
iNtRON Biotechnology Inc Company Snapshot
iNtRON Biotechnology Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares iNtRON Biotechnology Inc with three other companies in this sector in South Korea: Genexine Inc (2016 sales of 11.35 billion Korean Won [US$10.15 million] ), Panagene Inc (6.96 billion Korean Won [US$6.22 million] ), and Dna Link Inc (11.48 billion Korean Won [US$10.27 million] ).

Sales Analysis. iNtRON Biotechnology Inc reported sales of 10.22 billion Korean Won (US$9.14 million) for the year ending December of 2016. This represents a decrease of 13.6% versus 2015, when the company's sales were 11.84 billion Korean Won.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
iNtRON Biotechnology Inc
  Stock Performance Chart for iNtRON Biotechnology Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): 34,900
(Figures in Korean Won)
1 Week 9.6%   13 Weeks 9.4%  
4 Weeks 34.2%   52 Weeks -34.3%  
 
iNtRON Biotechnology Inc Key Data:
  Ticker: 048530 Country: Korea (South)
  Exchanges: SEO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 10,222,261,221
(Year Ending Jan 2017).
Employees: 101
  Currency: Korean Won Market Cap: 522,532,676,700
  Fiscal Yr Ends: December Shares Outstanding: 14,972,283
  Share Type: Ordinary Closely Held Shares: 3,266,541
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.